See what's happening at the American Society of Gene and Cell Therapy Annual Meeting (ASGCT) and explore solutions to streamline the commercialization of your cell or gene therapy product, including non-viral gene engineering, GMP reagents, spatial multi
(Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 –11, 2024, in Baltimore, ...
for serious diseases, today announced an oral presentation highlighting the Company's lipid nanoparticle (LNP) approach for ocular editing will be presented at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 –11, 2024, in Baltimore, ...
the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious latent viral infectious diseases, today announced presentation of six abstracts at the ASGCT 2024 Annual Meeting, which is being held from May...
CRISPR Therapeutics (Nasdaq: CRSP) today announced an oral presentation highlighting the Company’s lipid nanoparticle (LNP) approach for ocular editing will be presented at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting,...
The primary professional membership organization for gene and cell therapy’s annual meeting. Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory agencies, equipmen...
“Vitalgen”) will globally publish the updated data on the phase I/II clinical trial of gene therapy product VGR-R01 in patients with Bietti crystalline dystrophy (BCD) in oral presentation form for the first time in the 27thAnnual Meeting of American Society for Gene & Cell Therapy (ASGCT...
2024年5月9日,上海天泽云泰生物医药有限公司(以下简称“天泽云泰”)在巴尔的摩举行的第27届美国基因与细胞治疗学会(ASGCT)年会上以口头报告的形式全球首次公布了治疗结晶样视网膜变性(BCD)的基因治疗产品VGR-R01的临床I/II期最新数据,充分展示了VGR-R01的优异疗效和安全性优势。
line Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet needs in rare and severe diseases, presents data of multiple novel AAV gene therapy programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting....
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in cell and gene therapy. The five-day meeting is the best place for people in CGT to learn from the latest scientific research, stay up to date on new technologies, and make ca...